ArticleHepatology international2026
Cautious continuation: hepatic immune-related adverse events as a beacon for immune checkpoint inhibitor efficacy.
Yuhang Zhou et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it